Itafos Reports Strong Operational and Financial Q2 2024 Results

In This Article:

Itafos
Itafos

HOUSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Itafos Inc. (TSX-V: IFOS) (the “Company”) today reported its Q2 2024 financial results and provided a corporate update. The Company’s financial statements and management’s discussion and analysis for the three and six months ended June 30, 2024, are available under the Company’s profile at www.sedarplus.ca and on the Company’s website at www.itafos.com. All figures are in thousands of US Dollars except as otherwise noted.

CEO Commentary

“We are extremely pleased to report on the significant progress we have made on the execution of our strategic priorities in Q2, 2024. On the back of positive market fundamentals, the Company continues to report strong operational and financial performance,” said David Delaney. “Execution of the H1/NDR project continues, on time and on budget, as we derisk the project for first ore in H1 2025. We are also pleased to announce the sale of our Araxa project which will unlock value associated with our overseas asset portfolio. As we progress through 2024, the Board and Management will continue to focus on creating shareholder value.”

Q2 2024 Financial Highlights

For Q2 2024, the Company’s financial highlights were as follows:

  • Revenues of $105.1 million in Q2 2024 compared to $116.1 million in Q2 2023;

  • Adjusted EBITDA1 of $32.8 million in Q2 2024 compared to $39.7 million in Q2 2023;

  • Net income of $16.2 million in Q2 2024 compared to $20.4 million in Q2 2023;

  • Basic earnings of C$0.12/share in Q2 2024 compared to C$0.14/share in Q2 2023; and

  • Free cash flow1 of $42.5 million in Q2 2024 compared to $39.0 million in Q2 2023.

The decrease in the Company’s Q2 2024 financial performance compared to the corresponding period in the prior year was primarily due to lower sales volumes driven by lower production at Conda due to the completion of the large scope turnaround in 2024, which was partially offset by slightly higher realized prices.

The Company’s total capex1 spend in Q2 2024 was $30.2 million compared to $18.1 million in Q2 2023 with the increase primarily due to development activities at H1/NDR and large scope turnaround at Conda, as well as the sulfuric acid plant turnaround at Arraias.

H1 2024 Financial Highlights

For H1 2024, the Company’s financial highlights were as follows:

  • Revenues of $233.1 million in H1 2024 compared to $235.7 million in H1 2023;

  • Adjusted EBITDA of $76.0 million in H1 2024 compared to $82.6 million in H1 2023;

  • Net income of $39.9 million in H1 2024 compared to $48.6 million in H1 2023;

  • Basic earnings of C$0.28/share in H1 2024 compared to C$0.35/share in H1 2023; and

  • Free cash flow of $60.2 million in H1 2024 compared to $57.9 million in H1 2023.